Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StatePennsylvaniaReferred
HB 2770: An Act amending the act of June 13, 1967 (P.L.31, No.21), known as the Human Services Code, in public assistance, providing for drug cost transparency and pharmacy purchasing protections.
Dan Frankel
HB 2770 status: Referred — Referred to Health (updated Sep 14, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
69OUT OF 100
Score:69/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 60/100
Constitutionality85%
Bipartisan50%
Public opinion80%
Bill summary
What changes
The bill amends the Human Services Code to mandate transparency from drug manufacturers regarding pricing and establishes new regulatory protections for pharmacy purchasing.
Who is affected
Pharmaceutical companies, local pharmacies, and beneficiaries of state public assistance health programs.
Requirements and enforcement
Drug manufacturers must disclose pricing models; pharmacies receive updated procurement protections.
Costs and funding
Not stated in the available source.
When it takes effect
Currently in the House Health committee review stage.
Potential benefits
Potential for increased affordability and fairness in medication pricing and improved stability for independent pharmacies.
Risks and tradeoffs
Risk of market-leveling complications and potential administrative or supply-side hurdles for participants.
What is still unknown
The specific enforcement mechanisms for transparency and the impact on drug manufacturer participation are not explicitly defined in the available abstract.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
60%
Benefits
- Potential reduction in medicine costs for consumers
- Increased price transparency for state health programs
- Improved purchasing conditions for local pharmacies
Risks
- Uncertain compliance costs for drug manufacturers
- Risk of market distortion from pricing mandates
- Potential for supply chain adjustments by drug companies
Society
Positive outlook
75%
Benefits
- Improved affordability of essential medications
- Enhanced equity in pharmacy access for patients
- Direct benefit to public assistance recipients
Risks
- Risk of potential medication shortages
- Concerns regarding long-term program sustainability
- Dependence on pharmaceutical manufacturer cooperation
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Positive outlook
70%
Benefits
- Mandated disclosure of pharmaceutical pricing models
- Oversight of drug pricing practices
- Empowerment of state regulatory authority
Risks
- Potential for corporate resistance to disclosures
- Difficulty in auditing complex pharmaceutical pricing data
- Regulatory enforcement challenges for the state
Public Health & Safety
Positive outlook
70%
Benefits
- Enhanced access to life-sustaining medication
- Reduced financial barriers to patient care
- Increased stability for pharmacy service providers
Risks
- Potential for inconsistent medication availability
- Market-driven volatility in drug supply
- Implementation gaps in pharmacy support
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
Potential for market disruption and drug price shifts.
Analysis scope
Source limited to legislative abstract; full text unavailable.
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.